Unfortunately, even when a persons diet is rich in B12 or if they take a daily supplement, they may still be lacking, as vitamin B12 can be difficult to absorb orally
Great Taste, Easy to Take, It is recommended to take it first thing in the morning.

Ideal Candidates Include: People with Metabolic Dysfunction: Type 2 diabetes or pre-diabetes Insulin resistance Metabolic syndrome Obesity or trouble losing weight High triglycerides or cholesterol Fatty liver disease (NAFLD) PCOS (polycystic ovary syndrome) Those Experiencing Low Energy and Fatigue: Chronic fatigue syndrome Mitochondrial dysfunction Low energy despite adequate sleep Poor exercise tolerance or endurance Difficulty recovering from physical activity Athletes and Active Individuals: Wanting to improve endurance capacity Seeking better recovery between training sessions Looking to optimize body composition Aiming to enhance metabolic efficiency Preparing for competitions or events Aging Adults Focused on Longevity: Age 40+ seeking to prevent metabolic decline Interested in health span extension Wanting to maintain muscle mass and function Concerned about age-related disease prevention Seeking cognitive protection as they age Anyone Struggling With: Weight loss resistance despite diet and exercise Visceral (belly) fat accumulation Poor metabolic flexibility Brain fog and cognitive issues Declining physical performance with age Combining MOTS-C With Other Therapies MOTS-C works synergistically with other metabolic optimization strategies, often producing enhanced results when properly stacked

Whether or not it actually works is unclear as of 2019
Read More: To view or add a comment, sign in Safety of indwelling pleural catheter (IPC) use in patients undergoing chemotherapy, - a study by Charleen Chan Wah Hak, Parthipan Sivakumar, Liju Ahmed International guidelines for malignant pleural effusions recommend IPCs as a first-line treatment because they provide as effective symptom relief as chemical pleurodesis, with fewer days in hospital and less risk of treatment failure